The cornerstone of KXTbio’s technological success is Professor John Sondek’s 20 years of research experience in the area of drug screening. Dr. Sondek is KXTbio’s founder and Chief Scientific Officer (CSO); his research has provided the company with several patents. The Sondek lab is associated with the Departments of Pharmacology and Biochemistry & Biophysics at the University of North Carolina (UNC) at Chapel Hill.